OptimizeRx Q3 revenue beats estimates, raises 2025 revenue guidance

OptimizeRx

06/11/2025 21:14

Overview

OptimizeRx Q3 revenue increased 22% yr/yr, beating analyst expectations

Adjusted EBITDA for Q3 beats estimates, rising to $5.1 mln

Company raises full-year 2025 guidance, introduces 2026 guidance

OptimizeRx paid off $2 mln in principal from term loan after Q3

Outlook

Company raises 2025 revenue guidance to $105 mln-$109 mln

Company introduces 2026 revenue guidance of $118 mln-$124 mln

Company expects 2025 adjusted EBITDA of $16 mln-$19 mln

Result Drivers

REVENUE GROWTH - Co attributes 22% yr/yr revenue increase to effective execution and enhanced customer outcomes

TECHNOLOGY AND PARTNERSHIPS - Market-leading patient identification technologies and expanding partnerships drove results

LOAN REPAYMENT - Co paid off $2 mln in principal from term loan after Q3, reflecting financial discipline

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$26.10 mln
$23.83 mln (7 Analysts)
Q3 Adjusted Net Income
Beat
$3.90 mln
$977,830 (6 Analysts)
Q3 Adjusted EBITDA
Beat
$5.10 mln
$1.86 mln (7 Analysts)
Q3 Cash & Investments
$19.50 mln
Q3 Gross Profit
$17.50 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the online services peer group is "buy"

Wall Street's median 12-month price target for OptimizeRx Corp is $20.00, about 4.2% above its November 5 closing price of $19.16

The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 20 three months ago

Press Release: ID:nGNX3SlkFw

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)